Shenzhen Bioeasy Biotechnology Co. Ltd.
Shenzhen Bioeasy Biotechnology Co., Ltd., together with its subsidiaries, provides rapid food testing reagents and instruments in China and internationally. The company offers test kits, including veterinary, melamine, mycotoxin, pesticide, adulteration, ATP, vitamin, and others; equipment, such as incubator, reader, suitcase lab, automatic pressers, and others; and materials comprising pretreatm… Read more
Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.010x
Based on the latest financial reports, Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a cash flow conversion efficiency ratio of 0.010x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥9.12 Million) by net assets (CN¥910.35 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Shenzhen Bioeasy Biotechnology Co. Ltd. - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Shenzhen Bioeasy Biotechnology Co. Ltd.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Shenzhen Bioeasy Biotechnology Co. Ltd. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shenzhen Bioeasy Biotechnology Co. Ltd. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Blue Moon Zinc Corp
V:MOON
|
-0.049x |
|
HengFeng Information Technology Co Ltd
SHE:300605
|
0.077x |
|
River Financial Corporation
PINK:RVRF
|
0.089x |
|
Sino-Ocean Group Holding Limited
PINK:SIOLF
|
-5.547x |
|
Empery Digital Inc.
NASDAQ:EMPD
|
-0.017x |
|
Nanjing Chixia Development Co Ltd
SHG:600533
|
0.001x |
|
Wuxi Xinhongye Wire & Cable Co. Ltd. A
SHE:301310
|
N/A |
|
Lintes Technology Co Ltd
TW:6715
|
-0.007x |
Annual Cash Flow Conversion Efficiency for Shenzhen Bioeasy Biotechnology Co. Ltd. (2016–2024)
The table below shows the annual cash flow conversion efficiency of Shenzhen Bioeasy Biotechnology Co. Ltd. from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥870.24 Million | CN¥34.26 Million | 0.039x | +189.70% |
| 2023-12-31 | CN¥848.73 Million | CN¥-37.25 Million | -0.044x | -127.75% |
| 2022-12-31 | CN¥964.70 Million | CN¥152.55 Million | 0.158x | -41.40% |
| 2021-12-31 | CN¥946.58 Million | CN¥255.42 Million | 0.270x | +132.21% |
| 2020-12-31 | CN¥548.98 Million | CN¥63.79 Million | 0.116x | -8.70% |
| 2019-12-31 | CN¥528.32 Million | CN¥67.24 Million | 0.127x | -51.09% |
| 2018-12-31 | CN¥222.62 Million | CN¥57.93 Million | 0.260x | +26.35% |
| 2017-12-31 | CN¥114.60 Million | CN¥23.60 Million | 0.206x | -68.67% |
| 2016-12-31 | CN¥55.24 Million | CN¥36.31 Million | 0.657x | -- |